Gastroretentive extended release dosage form

A novel orally administrable dosage form including a drug/active layer for loading a therapeutic agent and an extension layer for retaining the API or drug dosage form in the stomach of a subject in need thereof. Also disclosed is a method of treating diseases with the dosage form.

Saved in:
Bibliographic Details
Main Authors Zhou, Fang, Fu, Shao
Format Patent
LanguageEnglish
Published 19.12.2023
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:A novel orally administrable dosage form including a drug/active layer for loading a therapeutic agent and an extension layer for retaining the API or drug dosage form in the stomach of a subject in need thereof. Also disclosed is a method of treating diseases with the dosage form.
Bibliography:Application Number: US202318177348